SciELO - Scientific Electronic Library Online

vol.29 issue2Usefulness of dietary enrichment on energy and protein intake in elderly patients at risk of malnutrition discharged to homePerception of physical fitness is associated with perception of body weight: sociodemographic analysis in Spain author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Nutrición Hospitalaria

On-line version ISSN 1699-5198Print version ISSN 0212-1611


AKHTAR, Reyhan; ALI, Mohd; MAHMOOD, Safrannisa  and  NATH SANYAL, Sankar. Anti-proliferative action of silibinin on human colon adenomatous cancer HT-29 cells. Nutr. Hosp. [online]. 2014, vol.29, n.2, pp.388-392. ISSN 1699-5198.

Background: Silibinin a flavonoid from milk thistle (Silybum marianum) exhibit a variety of pharmacological actions, including anti-proliferative and apoptotic activities against various types of cancers in intact animals and cancer cell lines. In the present study, the effect of silibinin on human colon cancer HT-29 cells was studied. Method: Incubations of cells with different silibinin concentrations (0.783-1,600 μg/ml) for 24, 48 or 72 h showed a progressive decline in cell viability. Results: Loss of cell viability was time dependent and optimum inhibition of cell growth (78%) was observed at 72 h. Under inverted microscope, the dead cells were seen as cell aggregates. IC50 (silibinin concentration killing 50% cells) values were 180, 110 and 40μg/ml at 24, 48 and 72 h respectively. Conclusion: These findings re-enforce the anticancer potential of silibinin, as reported earlier for various other cancer cell lines (Ramasamy and Agarwal (2008), Cancer Letters, 269: 352-62).

Keywords : Colon cancer; HT-29; Proliferation; Silibinin.

        · abstract in Spanish     · text in English     · English ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License